National Health (Pharmaceutical Benefits) Regulations (Amendment) (Cth)

STATUTORY RULES.

1963. No. 107.

REGULATIONS UNDER THE NATIONAL HEALTH ACT 1953-1962.*

I, THE GOVERNOR-GENERAL in and over the Commonwealth of Australia, acting with the advice of the Federal Executive Council, hereby make the following Regulations under the National Health Act 1953-1962.

Dated this thirty-first

day of October , 1963.

DE L’ISLE

Governor-General.

By His Excellency’s Command,

Sgd. H. W. Wade

Minister of State for Health.

Amendments of the National Health (Pharmaceutical Benefits) Regulations. 

Commencement.

1. These Regulations shall come into operation on the first day of November, 1963.

First, Second, Third, Fourth and Fifth Schedules.

2. The First, Second, Third, Fourth and Fifth Schedules to the National Health (Pharmaceutical Benefits) Regulations are repealed and the following Schedules inserted in their stead:—

 

First Schedule.

Regulation 10.

DRUGS AND MEDICINAL PREPARATIONS IN THE BRITISH PHARMACOPOEIA THAT ARE NOT TO BE SUPPLIED AS, OR USED IN, PHARMACEUTICAL BENEFITS EXCEPT AS SPECIALLY PROVIDED.

Absorbable Gelatin Sponge.

Acetazolamide.

Acetomenaphthone.

Adrenaline Acid Tartrate.

Alcohol.

Amethocaine Hydrochloride.

Amethocaine Injection.

Amodiaquine Hydrochloride.

Amphetamine.

Amphetamine Sulphate.

Amylobarbitone Sodium Tablets.

Antimony Potassium Tartrate.

Antimony Sodium Tartrate.

Antimony Sodium Tartrate Injection.

Apomorphine Hydrochloride.

Apomorphine Injection.

Azovan Blue.

Bacillus Calmette-Guerin Vaccine.

Bacitracin.

Bemegride.

Benzhexol Hydrochloride.

Bismuth Oxychloride.

Bismuth Oxychloride Injection.

Bismuth Sodium Tartrate.

Busulphan.

Butobarbitone.

* Notified in the Commonwealth Gazette on 31st October, 1963.

  Statutory Rules 1960, No. 17, as amended by Statutory Rules 1960, Nos. 90 and 102; 1961, Nos. 59 and 137; 1962, Nos. 34, 101 and 114; and 1963, Nos. 34 and 69.

9808/63.—Price 1s. 9/18.10.1963.

First Schedule—continued.

Calciferol.

Camphor Water.

Caraway.

Carbachol.

Carbimazole.

Carbon Dioxide.

Carbromal Tablets.

Cardamom Fruit.

Catgut, sterilized surgical.

Cellulose Oxidized.

Chlorcyclizine Hydrochloride.

Chloroxylenol.

Chorionic Gonadotrophin.

Chloroquine Phosphate.

Chloroquine Sulphate.

Chlorothiazide.

Chloroxylenol.

Chlortetracycline Injection.

Cinchocaine Hydrochloride.

Cinnamon.

Cochineal.

Cod Liver Oil.

Colchicine.

Colchicum Corm.

Coriander.

Corticotrophin.

Cresol.

Cresol and Soap Solution.

Cyanocobalamin.

Cyclobarbitone.

Cyclopropane.

Dapsone.

Dexamphetamine Sulphate.

Dextran Injection.

Dextran Sulphate.

Dextran Sulphate Injection.

Dick Control.

Dick Test Toxin.

Diethylcarbamazine Citrate.

Digitalis Leaf.

Dimercaprol.

Diodone Injection.

Diphtheria and Pertussis Vaccine.

Dithranol.

Emetine and Bismuth Iodide.

Emetine Hydrochloride.

Ergometrine Maleate.

Ether Vinyl.

Ethinyloestradiol.

Ethisterone.

Ethopropazine Hydrochloride.

Ethyl Biscoumacetate.

Ethyl Chloride.

Ethylenediamine Hydrate.

Ethyl Oleate.

Gallamine Triethiodide.

Gallamine Injection.

Gentian.

Gentian Compound Infusion.

Ginger.

Halothane.

Hamamelis.

Helium.

Heparin.

Hexamethonium Tartrate.

Hexamethonium Tartrate Tablets.

Hexamethonium Tartrate Injection.

Hexylresorcinol.

Histamine Acid Phosphate.

Human Blood, whole.

Human Red Blood Corpuscles,

   concentrated.

Human Fibrin Foam.

Human Fibrinogen.

Human Gamma Globulin.

Human Gamma Globulin Injection.

Human Serum, dried.

Human Serum, liquid.

Human Plasma, dried.

Human Thrombin.

Hydrocortisone Acetate Ointment.

Hydrocortisone Hydrogen Succinate.

Hydrocortisone Ointment.

Hydrogen Peroxide Solution, strong.

Hydroxychloroquine Sulphate.

Hyoscine Eye Ointment.

Hyoscyamus.

Indigo Carmine.

Iodised Oil Injection.

Iodoxyl.

Iopanoic Acid.

Iopanoic Acid Tablets.

Ipecacuanha.

Ipecacuanha, prepared.

Ipecacuanha and Opium Tablets.

Isoniazid.

Lead Acetate.

Lead Monoxide.

Lemon Peel, dried.

Lemon Peel, fresh.

Leptazol.

Lignocaine and Adrenaline Injection.

Lignocaine Hydrochloride.

Lignocaine Hydrochloride Injection.

Liothyronine Sodium.

Liothyronine Tablets.

Lucanthone Hydrochloride.

Male Fern.

Male Fern Extract.

Maleic Acid.

Mannitol.

Mepacrine Hydrochloride.

Mephenesin.

Mephenesin Injection.

Mercaptofurine.

Mercuric Oxide, yellow.

Mercury.

Mersalyl Acid.

Methadone Hydrochloride.

Methoin.

Methyltestosterone.

Methylamphetamine Hydrochloride.

Methylthiouracil.

Mustine Hydrochloride.

Nalorphine Hydrobromide.

Naphazoline Hydrochloride.

First Schedule—continued.

Neostigmine Bromide.

Neostigmine Methylsulphate.

Nicotinic Acid.

Nikethamide.

Nikethamide Injection.

Nitrous Oxide.

Nux Vomica.

Oestradiol Benzoate.

Opium.

Opium, powdered.

Orange Peel, dried bitter.

Orange Peel, fresh bitter.

Ouabain.

Oxygen.

Oxytetracycline Dihydrate.

Paramethadione.

Pentamidine Injection.

Pentamidine Isethionate.

Pethidine Tablets.

Phenindamine Tartrate.

Phenindione.

Pheniodol.

Phenolphthalein Tablets.

Phenolsulphonphthalein.

Phytomenadione.

Phytomenadione Capsules.

Picrotoxin.

Poliomyelitis Vaccine.

Potassium Perchlorate.

Prednisone Acetate.

Primaquine Phosphate.

Primidone.

Probenecid.

Procyclidine Hydrochloride.

Procaine and Adrenaline Injection.

Progesterone.

Proguanil Hydrochloride.

Propyliodone.

Propyliodone Injection.

Propyliodone Oily Injection.

Propyl Thirouracil.

Pyridostigmine Bromide.

Pyrimethamine.

Quillaia.

Senna Leaf.

Sesame Oil.

Soda Lime.

Sodium Aminosalicylate Tablets.

Sodium Antimonylgluconate.

Sodium Antimonylgluconate Injection.

Sodium Aurothiomalate.

Sodium Radio-iodide (131I) Injection.

Sodium Radio-iodide (131I) Solution.

Sodium Radiophosphate (32P) Injection.

Sodium Radiophosphate (32P) Solution.

Sodium Stibogluconate.

Sodium Stibogluconate Injection.

Solapsone.

Solapsone Tablets.

Stibophen.

Stramonium Dry Extract.

Sulphadimidine Sodium.

Suramin.

Suxamethonium Bromide.

Suxamethonium Chloride.

Testosterone.

Tetrachloroethylene.

Tetrachloroethylene Capsules.

Thiomersal.

Thiopentone Sodium.

Thiopentone Injection.

Thyroid.

Thyroxine Sodium.

Tolazoline Hydrochloride.

Tolbutamide.

Trichloroethylene.

Tryparsamide.

Tuberculin, old.

Tuberculin Purified Protein Derivative.

Tubocurarine Chloride.

Tubocurarine Injection.

Typhoid-Paratyphoid A and B and Cholera Vaccine.

Typhoid-Paratyphoid A and B Tetanus Vaccine.

Yellow Fever Vaccine.

Second Schedule.

Regulation 10 (3).

DRUGS AND MEDICINAL PREPARATIONS THAT ARE PHARMACEUTICAL BENEFITS ONLY WHEN PRESCRIBED FOR USE IN A DETERMINED FORM OR IN ALLOWABLE COMPOUNDS.

Pharmaceutical Benefit.	Allowable Compounds (if any).
Dried Aluminium Hydroxide Gel. B.P.	Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
Dried Aluminium Hydroxide Gel. B.P. with Magnesium Carbonate B.P.
Aluminium Hydroxide Gel. B.P. ............	Aluminium Hydroxide Gel. B.P. with Light Magnesia B.P.
Aluminium Hydroxide Gel. B.P. with Magnesium Trisilicate B.P. and Magnesium Hydroxide B.P.
Aluminium Hydroxide Gel. B.P. with Kaolin Light B.P. and Pectin
Aluminium Hydroxide Gel. B.P. with Magnesium Hydroxide
Aluminium Hydroxide Gel. with Magnesium Trisilicate B.P.
Aluminium Powder ..............................	Aluminium Powder with Zinc Oxide B.P. and Liquid Paraffin B.P.
Aneurine Hydrochloride B.P. ................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Ascorbic Acid B.P. ...............................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Bendrofluazide .....................................	—
Benethamine Penicillin .........................	Benethamine Penicillin with Procaine Penicillin B.P. and Benzylpenicillin Sodium B.P.
Benzalkonium Chloride ........................	—
Benzathine Penicillin B.P. .....................	Procaine Penicillin B.P. with Benzylpenicillin B.P. and Benzathine Penicillin B.P.
Benzylpenicillin B.P. ............................	Fortified Procaine Penicillin Injection B.P.
Benzylpenicillin B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
Procaine Penicillin B.P. with Benzylpenicillin B.P. and Benzathine Penicillin B.P.
Benzylpenicillin Sodium B.P. ................	Streptomycin Sulphate B.P. with Benzylpenicillin Sodium B.P.
Benethamine Penicillin with Procaine Penicillin B.P. and Benzylpenicillin Sodium B.P.
Betamethasone Phosphate .....................	—
Bismuth Subnitrate B.P.C. ....................	Resorcinol B.P. with Bismuth Subnitrate B.P.C, Zinc Oxide B.P., Starch B.P., Cade Oil B.P., Wool Fat B.P., Sodium Metabisulphite, Water, Hard Paraffin B.P. and Yellow Soft Paraffin B.P.
Butabarbital Sodium .............................	—
Carbromal B.P. ....................................	Pentobarbitone Sodium B.P. with Carbromal B.P.
Chloramphenicol B.P. ...........................	Chloramphenicol B.P. with Borate Buffer and Sterile Distilled Water
Chloramphenicol B.P. with Propylene Glycol B.P.
Chloramphenicol B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Chloramphenicol B.P. with Polymyxin B. Sulphate B.P.

Second Schedule—continued.

Pharmaceutical Benefit.	Allowable Compounds (if any).
Chlorhexidine Diacetate .........................	—
Chlorpromazine Hydrochloride B.P. .......	—
Chlortetracycline Calcium ......................	—
Chlortetracycline Hydrochloride B.P. ......	Chlortetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Clemizole ..............................................	—
Cortisone Acetate B.P. ...........................	—
Cyclizine Hydrochloride ........................	Cyclizine Hydrochloride with Caffeine B.P. and Ergotamine Tartrate B.P.
Demethylchlortetracycline Hydrochloride	—
Dexamethasone Sodium Phosphate .........	—
Dextrochlorpheniramine Maleate ............	—
Dicyclomine Hydrochloride ...................	—
Dienoestrol B.P. ....................................	—
Diethyl Dithiolisophthalate .....................	—
Diiodohydroxyquinoline B.P. .................	—
Diphtheria Vaccine B.P. .........................	Diphtheria, Tetanus and Pertussis Vaccine B.P.
Diphtheria and Tetanus Vaccine B.P.
Diphtheria and Tetanus Vaccine B.P. ......	—
Ergotamine Tartrate B.P. ........................	Ergotamine Tartrate B.P. with Caffeine B.P.
Ergotamine Tartrate B.P. with Caffeine Citrate B.P.C. and Diphenhydramine Hydrochloride B.P.
Ergotamine Tartrate B.P. with Caffeine B.P. and Meclozine Hydrochloride B.P.
Ergotamine Tartrate B.P. with Caffeine B.P. and Cyclizine Hydrochloride
Erythromycin B.P. .................................	—
Ethotoin ................................................	—
Ferrous Aminoacetosulphate ..................	—
Ferrous Succinate ..................................	—
Glucose Indicator ..................................	—
Gramicidin ............................................	Gramicidin with Polymyxin B. Sulphate B.P. and Neomycin Sulphate B.P.
Griseofulvin ..........................................	—
Guanethidine Sodium .............................	—
Haemophilus Influenza Bacterial Serum	—
Hamamelis Dry Extract ..........................	Hamamelis Dry Extract with Zinc Oxide B.P. and Theobroma Oil B.P.
Hexocyclium Methyl Sulphate ................	—
Hydrocortisone B.P. ...............................	—
Hydrocortisone Acetate B.P. ..................	Hydrocortisone Acetate B.P. with Neomycin Sulphate B.P.
Hydrocortisone Sodium Succinate ..........	—
Isoprenaline Hydrochloride ....................	—
Isopropamide Iodide ..............................	—
Levallorphan Tartrate .............................	Levallorphan Tartrate with Pethidine Hydrochloride B.P.
Lofenalac ..............................................	—
Meclozine Hydrochloride B.P.C. ............	—
Mercuric Oxide Eye Ointment B.P. .........	—
Methazolamide ......................................	—
Methscopolamine Bromide .....................	—
Methyclothiazide ...................................	—
Methylphenobarbitone B.P.C. .................	—
Methylprednisolone ...............................	—
Minafen ................................................	—
Naphazoline Nitrate B.P. ........................	Antazoline Hydrochloride B.P. with Naphazoline Nitrate B.P.

Second Schedule—continued.

Pharmaceutical Benefit.	Allowable Compounds (if any).
Neomycin Sulphate B.P., Eye Drops .........	Polymyxin B. Sulphate B.P. with Bacitracin B.P., Neomycin Sulphate B.P. and Paraffin Base
Neomycin Sulphate B.P. with Bacitracin B.P and Polymyxin B. Sulphate B.P
Neomycin Sulphate B.P. with Polymyxin B. Sulphate B.P. and Gramicidin
Nicotinamide B.P. ....................................	Vitamin A with Aneurine Hydrochloride B.P. Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Oestrone ..................................................	—
Oleandomycin .........................................	Tetracycline with Oleandomycin
Oleoresin Capsicum .................................	Bile Salts with Cascara Sagrada B.P., Phenolphthalein B.P. and Oleoresin Capsicum
Oxyphencyclimine Hydrochloride .............	—
Oxyphenonium Bromide ..........................	—
Oxytetracycline Hydrochloride B.P. ..........	Oxytetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Papaveretum B.P.C. .................................	Papaveretum B.P.C. with Hyoscine Hydrobromide B.P.
Papaverine Hydrochloride ........................	—
Pancreatin B.P. ........................................	—
Pempidine Tartrate ...................................	—
Pentolinium Tartrate B.P. .........................	Pentolinium Tartrate B.P. with Ephedrine B.P.
Pethidine Hydrochloride B.P. ...................	Pethidine Hydrochloride B.P. with Hyoscine Hydrobromide B.P.
Pethidine Hydrochloride B.P. with Levallorphan Tartrate
Pertussis Vaccine B.P. ..............................	Diphtheria, Tetanus and Pertussis Vaccine B.P.
Diphtheria and Pertussis Vaccine B.P.
Phenoxymethylpenicillin B.P. ...................	—
Phenoxymethylpenicillin (Benzathine Salt)	—
Phenoxymethylpenicillin Calcium B.P.	—
Phenoxymethylpenicillin (Hydrabamine Salt)	—
Phenoxymethylpenicillin Potassium B.P.	—
Pipenzolate ..............................................	—
Polydimethylsiloxanes .............................	—
Polymyxin B. Sulphate B.P. ......................	Polymyxin B. Sulphate B.P. with Mucilage of Methylcellulose and Distilled Water B.P.
Polymyxin B. Sulphate B.P. with Bacitracin B.P., Neomycin Sulphate B.P. and Paraffin Base
Polymyxin B. Sulphate B.P. with Ophthalmic Phosphate Buffer
Polymyxin B. Sulphate B.P. with Acetic Acid B.P. and Propylene Glycol B.P.
Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Bacitracin B.P.
Polymyxin B. Sulphate B.P. with Tetracycline Hydrochloride
Polymyxin B. Sulphate B.P. with Neomycin Sulphate B.P. and Gramicidin
Polymyxin B. Sulphate B.P. with Chloramphenicol B.P.
Prednisolone B.P. ....................................	Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
Prednisolone B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.

Second Schedule—continued.

Pharmaceutical Benefit.	Allowable Compounds (if any).
Prednisolone Disodium Phosphate ............	—
Prednisone B.P. .......................................	Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.
Procaine Hydrochloride B.P. ....................	Procaine Hydrochloride B.P. in Normal Saline
Tetracycline and Procaine Injection B.P.
Pyrazinamide ..........................................	—
Pyridine Aldoxime Methiodide .................	—
Pyrimido-Pyrimidine ...............................	—
Pyrrolidino-Methyl-Tetracycline ..............	—
Rauwolfia Alkaloids ................................	—
Roserpine B.P. ........................................	—
Riboflavine B.P. ......................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Sobee ......................................................	—
Sodium Chloride B.P. with Potassium Chloride B.P. and Hydrated Calcium Chloride B.P. in Water for Injection B.P.	Sodium Chloride B.P. with Potassium Chloride B.P., Hydrated Calcium Chloride B.P., Water for Injection B.P. and Dextrose B.P.
Compound Sodium Lactate Injection B.P.	Compound Sodium Lactate Injection B.P. with Dextrose B.P.
Sodium Lauryl Sulphate B.P. ...................	Emulsifying Wax B.P.
Streptomycin Sulphate B.P. ......................	Benzylpenicillin B.P. with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.
Benzylpenicillin Sodium B.P. with Streptomycin Sulphate B.P.
Streptomycin Sulphate B.P., with Normal Saline
Sulphadimidine B.P. ................................	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphadimidine B.P.
Sulphamerazine B.P. ................................	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphadimidine B.P.
Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphathiazole
Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphacetamide
Sulphacetamide .......................................	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphacetamide
Sulphathiazole .........................................	Sulphadiazine B.P. with Sulphamerazine B.P. and Sulphathiazole
Tacrine ...................................................	Tacrine with Morphine
Terpineol B.P. .........................................	Solution of Chloroxylenol B.P.
Tetanus Vaccine B.P. ...............................	Diphtheria, Tetanus and Pertussis Vaccine B.P.
Tetracycline Hydrochloride B.P. ...............	Tetracycline Hydrochloride B.P. with Nystatin
Tetracycline and Procaine Injection B.P.
Tetracycline Hydrochloride B.P. with a buffering agent
Tetracycline Hydrochloride B.P. with Liquid Paraffin B.P. and White Soft Paraffin B.P.
Tetracycline ............................................	Tetracycline with Oleandomycin
Thenalidine .............................................	Thenalidine with Calcium Lactate B.P. and Calcium Gluconate B.P.
Theobroma Prepared B.P.C. .....................	Calcium Gluconate B.P. with Sucrose B.P., Vanillin B.P. and Theobroma Prepared B.P.C.
Triamcinolone .........................................	—
Trifluoperazine ........................................	—
Tricyclamol Chloride ...............................	—
Tripelennamine Hydrochloride .................	—
Troxidone B.P. ........................................	—
Typhoid Para-Typhoid A and B Vaccine B.P.	Typhoid Para-Typhoid A, B and C Vaccine B.P.

Second Schedule—continued.

Pharmaceutical Benefit.	Allowable compounds (if any).
Viomycin Pantothenate .........................	Viomycin Sulphate and Viomycin Pantothenate
Viprynium Embonate ............................	—
Concentrated Vitamin A Solution B.P.	Concentrated Vitamins A and D Solution B.P.
Concentrated Vitamin D Solution B.P.	Concentrated Vitamins A and D Solution B.P.
Vitamin D ............................................	Vitamin A with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D
Yellow Mercuric Oxide B.P. .................	Mercuric Oxide Eye Ointment B.P.

Third Schedule.

Regulation 11.

PHARMACEUTICAL BENEFITS ADDITIONAL TO PHARMACEUTICAL BENEFITS IN THE BRITISH PHARMACOPOEIA.

Acetazolamide Sodium.

Acetohexamide.

Acetyl-Sulphamethoxypridazine.

Aconite Liniment, B.P.C.

Acriflavine, B.P. 1948.

Acrylic Rosin.

Adrenaline Hydrochloride Solution, B.P. 1953.

Adrenaline Mucate.

Agar, B.P.C.

Aloes Pill, B.P. 1948.

Aloin, B.P. 1953.

Aloxidone.

Aluminium Acetate Solution, B.P.C.

Aluminium Powder.

Amaranth Solution, A.P.F.

Amaranth Solution, B.P.C. 1954.

Amidopyrine, B.P.C. 1954.

Ammonium Acetate, Strong Solution, B.P. 1953.

Ammonium Bicarbonate, B.P. 1953.

Ammonium Bromide, B.P.C.

Amphotericin B.

Ampicillin.

Androstanolone.

Aniseed Water, concentrated, B.P.C.

Aniseed Spirit, B.P.C. 1949.

Aromatic Ammonia Spirit, B.P. 1953.

Aurothioglucose.

Balsam of Peru, B.P.C.

Beeswax, Yellow, B.P.C.

Belladonna Suppository, B.P. 1948.

Bendrofluazide.

Benzalkonium Chloride.

Benzoinated Lard, B.P.C. 1954.

Benzol (Commercial).

Benzylpenicillin in Oil.

Bephenium Hydroxynaphthoate.

Betamethasone.

Betamethasone Phosphate.

Bismuth Glycollylarsanilate.

Bismuth Subgallate, B.P.C.

Bismuth Subnitrate, B.P.C.

Bretylium Tosylate.

Brown Snake Antivenene.

Buchu Concentrated Infusion, B.P.C. 1954.

Butabarbital Sodium.

Butyl Aminobenzoate, B.P. 1953.

Caffeine Citrate, B.P.C.

Cajuput Spirit, B.P. 1948.

Calamine Cream, A.P.F.

Calcium Aurothiomalate.

Calcium Di-Oxytetracycline.

Calcium Aminosalicylate, B.P.C.

Calcium Phosphate, B.P. 1953.

Caluma Concentrated Infusion, B.P. 1948.

Calumba Tincture, B.P. 1948.

Camphor Water, concentrated, B.P.C. 1949.

Capsicum Ointment, B.P.C.

Capsicum Tincture, B.P.C.

Caramiphen Hydrochloride.

Caraway Oil, B.P.C.

Carbinoxamine Maleate.

Cardamom Aromatic Tincture, B.P.C.

Carmine Solution, A.P.F.

Catechu Tincture, B.P.C.

Cetyl Alcohol Compound.

Charcoal.

Chlorambucil.

Chloramine, B.P.C.

Chlorazanil.

Chlorhexidine Diacetate.

Chlorobenzol Disulphonamide.

Chloroform Water, concentrated, B.P.C.

Chlorotrianisene, B.P.C.

Chlorpheniramine Maleate.

Chlorpropamide.

Chlortetracycline Calcium.

Chlorthalidone.

Spirit of Cinnamon, B.P.C. 1949.

Clemizole Hydrochloride.

Clemizole Tannate Syrup.

Cloves, Concentrated Infusion, B.P.C. 1954.

Cloxacillin.

Cochineal Tincture, B.P. 1948.

Coconut Oil, B.P.C. 1949.

Codeine, B.P.C. 1954.

Cod Liver Oil Emulsion, B.P. 1953.

Colchicine Salicylate.

Colistin.

Colocynth and Hyoscyamus Pill, B.P.C.

Colocynth, B.P.C.

Compound Effervescent Powder, B.P. 1953.

Creosote, B.P. 1953.

Crude Coal Tar.

Cudbear Tincture, A.P.F. 1947.

Cyclizinc Hydrochloride.

Cyclopenthiazide.

Cyclophosphamide.

Cycloserine.

Cycrimine Hydrochloride.

Cymogran.

Cyproheptadine.

Darrow’s Solution.

Death Adder Antivenene.

Demecarium Bromide.

Demethylchlortetracycline Hydrochloride.

Desferrioxamine.

Deslanoside.

Dexamethasone.

Dexamethasone Sodium Phosphate.

Dextran Iron.

Dextrin Iron.

Third Schedule—continued.

Dextrochlorpheniramine Maleate.

Dichlorphenamide.

Dicyclomine Hydrochloride.

Diethyl Dithiolisophthalate.

Diloxanide Furoate.

Digitoxin, B.P.C.

Dihydroergotamine.

Dihydromorphinone Hydrochloride, B.F.C. 1949.

Diphenylpyraline Hydrochloride.

Diphtheria Toxoid Purified.

Dipyridamole.

Disodium Diethylstilboestrol Diphosphate.

Disodium Dihydrogen Versenate.

Dithiazanine Iodide.

Dyflos, B.P.C.

Ecothiopate Iodide.

Ephedrine Sulphate, B.P.C. 1954.

Ergot Liquid Extract, B.P.C. 1954.

Erythrityltetranitrate, B.P.C. 1949.

Erythromycin Glucoheptonate.

Erythromycin Propionate.

Erythromycin Stearate.

Ethionamide.

Ethosuximide.

Ethotoin.

Ethoxzolamide.

Ethylidene Dicoumarin.

Ethylnoradrenaline.

Ferric Hydroxide.

Ferrous Aminoacetosulphate.

Ferrous Phosphate Compound Syrup, B.P.C.

Ferrous Phosphate with Quinine and Strychnine Syrup, B.P.C.

Ferrous Succinate.

Fludrocortisone Acetate.

Fluoxymesterone.

Formyl-Tetrahydropteroyl Glutamic Acid.

Framycetin Sulphate.

Fructose, B.P. 1948.

Gall with Opium Ointment, B.P.C.

Gelsemium Tincture, B.P.C.

Gentian Violet.

Glucagon Hydrochloride.

Glucose Indicator.

Glucose Liquid, B.P. 1953.

Glutethimide, B.P.C.

Glycerophosphates Compound Syrup, A.P.F.

Gramicidin.

Griseofulvin.

Guanethidine Sodium.

Guanethidine Sulphate.

Haemophilus Influenza Bacterial Serum.

Hamamelis Dry Extract.

Heparin Retard.

Hexachlorophene, 3% with Entsufon.

Hexachlorophene, 3% with Lissapol.

Hexachlorophene, 1.5% with Soap Solution.

Hexachlorothiazide.

Hexocyclium Methyl Sulphate.

Hexoestrol.

Honey, Purified, B.P.C.

Hydrocalciferol.

Hydrocyanic Acid Dilute, B.P.C. 1954.

Hydroflumethiazide.

Hydroxocobalamin.

Hypophosphorous Acid Dilute, B.P.C.

Insulin Injection (Specially Purified).

Insulin Isophone (N.P.H.).

Insulin Isophane (N.P.H.), (Specially Purified).

Insulin Special P (Pig).

Iodochlorhydroxyquinoline.

Iodoform B.P.C.

Iodoform Suppository, B.P. 1948.

Ipomoea Resin.

Iron Aminote.

Iron Carbonate Saccharated, B.P.C.

Iron Oxide Saccharated.

Iron Carbohydrate Complex.

Iron Phosphate Compound Syrup, B.P.C.

Isoprenaline Hydrochloride.

Isopropamide Iodide.

Isothipendyl Hydrochloride.

Kanamycin Sulphate.

Lavender Oil, Spike, B.P.C.

Lemon Syrup, neutral, A.P.F.

Levallorphan Tartrate.

Levorphanol Tartrate, B.P.C.

Liothyronine.

Lissapol, N 100.

Lobelia Ethereal Tincture, B.P.C.

Lofenalac.

Magenta, B.P.C.

Magnesium Bicarbonate Solution, B.P. 1948.

Mebhydrolin.

Mecamylamine.

Mecholyl Chloride.

Medroxyprogesterone Acetate.

Meclozine Hydrochloride, B.P.C.

Mephentermine Sulphate.

Mercaptomerin Sodium.

Mercuric Chloride, B.P. 1953.

Mercurous Chloride Ointment, B.P. 1948.

Mercury Compound Ointment, B.P.C.

Metaraminol.

Metformin.

Methazolamide.

Methdilazine Hydrochloride.

Methenamine Mandelate.

Methenolone Acetate.

Methenolone Oenanthate.

Methicillin.

Methotrexate.

Methoxamine Hydrochloride, B.P.C.

Methscopolamine Bromide.

Methyclothiazide.

Methyl Androstanolone.

Methyl Atropine Nitrate.

Methylcellulose, A.P.F.

Methylcellulose Mucilage, A.P.F.

Third Schedule—continued.

Methyldopa.

Methyl Prednisolone.

Methyl Prednisolone Acetate.

Methylandrostenediol.

Methylphenobarbitone, B.P.C.

Metronidazole.

Milk Powder, Synthetic.

Minafen.

Mitomycin.

Myrrh, B.P.C.

Myrrh Tincture, B.P.C.

Nandrolone Decanoate.

Nandrolone Phenylpropionate.

Nicoumalone.

Niclosamide.

Nitrofurantoin.

Nitromin.

Nitrous Ether Spirit, B.P.C.

Norethandrolone.

Nux Vomica Extract, Dried, B.P. 1953.

Nystatin.

Oestradiol Dipropionate.

Oestrone.

Oleandomycin.

Oleoresin Capsicum.

Orange Peel Infusion Concentrated, B.P. 1948.

Orange Peel Infusion Concentrated, Compound, B.P.C.

Orciprenaline.

Ox-Bile Extract, B.P. 1948.

Oxymel, B.P.C.

Oxymel of Squill, B.P.C.

Oxymesterone.

Oxyphencyclimine Hydrochloride.

Oxyphenonium Bromide.

Oxytocin Nasal Spray.

Pancreatin 4, U.S.N.F. XI.

Para-Aminosalicyclic Acid.

Paraben Ophthalmic Phosphate Buffer, A.P.F.

Paraben Ophthalmic, Vehicle, A.P.F.

Paracetamol.

Paramethasone Acetate.

Papaveretum, B.P.C.

Pectin.

Pempidine Tartrate.

Penicillin Benethamine.

Penicillinase.

Pentaerythritol Tetranitrate.

Penthienate.

Pertussis Prophylactic (Haemagglutinin Aluminium Phosphate Adsorbed).

Phenazone, B.P.C.

Phenazopyradine Hydrochloride.

Phenethicillin.

Phenformin.

Phenoxymethylpenicillin (Benzathine Salt).

Phenoxymethylpenicillin (Hydrabamine Salt).

Phensuximide.

Phenylbutazone.

Phenylmercuric Dinaphthylmethane Disulphonate.

Phenytoin.

Pholcodine, B.P.C.

Pholcodine Citrate Syrup, B.P.C.

Phthalylsulphacetamide.

Physostigmine Alkaloid.

Pipenzolate.

Pituitary (Posterior Lobe).

Polydimethylsiloxanes.

Polythiazide.

Potash Sulphurated, B.P.C.

Potassium Chlorate, B.P.C.

Prednisolone Disodium Phosphate.

Prednisolone Sodium Hemisuccinate.

Prednisolone Trimethylacetate.

Prophenpyridamine Maleate.

Prophenpyridamine Para-Aminosalicylate.

Propylthiouracil, B.P.C.

Protamine Sulphate.

Protoveratrines A.

Pyrazinamide.

Pyridine Aldoxime Methiodide.

Pyridoxine Hydrochloride, B.P.C.

Pyrrolidino-Methyl-Tetracycline.

Quassia Tincture, B.P. 1948.

Quillaia Tincture, B.P.C.

Quinethazone.

Rauwolfia Alkaloids.

Red Back Spider Antivenene.

Red Syrup.

Rheomacrodex, 10% in Dextrose.

Ristocetin.

Salicylamide.

Salicylazosulphapyridine.

Senega Concentrated Infusion, B.P.C.

Senna Compound Mixture, B.P.C.

Senna Fruit Extract.

Senna Leaf Concentrated Infusion, B.P.C.

Siberian Fir Oil, B.P.C. 1949.

Silver Picrate, B.P.C. 1949.

Silver Protein Mild, B.P.C.

Soap Curd, B.P.C.

Soap, Hard. B.P.C.

Sobee.

Sodium Calcium Edetate.

Sodium Carbonate Exsiccated, B.P.C.

Sodium Folate.

Sodium Lactate.

Sodium Nitrite, B.P.C.

Sodium Oleate Acid.

Sodium Tauroglycocholate.

Sorbolene, A.P.F.

Spearmint Oil.

Spiramycin.

Spironolactone.

Squill Syrup, B.P.C.

Squill Tincture.

Squill Vinegar, B.P. 1948.

Stearic Acid, B.P.C.

Strophanthus Tincture, B.P. 1948.

Strychnine, B.P.C.

Sulfinpyrazone.

Sulphacetamide.

Sulphadiazine Sodium.

Sulphadimethoxine.

Third Schedule—continued.

Sulphamethoxydiazine.

Sulphamethoxypyridazine.

Sulphafurazole.

Sulphamethizole.

Sulphaphenazole.

Sulphathiazole.

Sulphapyridine, B.P.C.

Sulphuric Acid Dilute, B.P.C.

Sulthiame.

Surgical Cement.

Sustanon.

Syntocinon.

Tacrine.

Taipan Antivenene

Talc Purified, B.P.C

Testosterone Oenanthate

Tetanus Toxoid, Purified Aluminium Phosphate Adsorbed.

Tetracycline.

Thenalidine Tartrate.

Theobromine, B.P.C.

Theobroma Prepared, B.P.C.

Thiacetazone.

Thiambutosine.

Thioridazine Hydrochloride.

Thyrotrophin.

Tiger Snake Antivenene.

Tretamine.

Triamcinolone.

Triamterene.

Triaziquone.

Tricyclamol Chloride.

Triethanolamine, B.P.C.

Triethanolamine Trinitrate.

Triethylene Thiophosphoramide.

Trifluoperazine.

Trimeprazine Tartrate.

Trimetaphan Camphorsulphonate.

Trinitrophenol, B.P.C.

Triprolidine Hydrochloride.

Vadrine.

Valerian Ammoniated Tincture, B.P.C.

Vancomycin Hydrochloride.

Vasopressin Tannate in Oil.

Velactin.

Veriloid.

Viomycin Pantothenate.

Viomycin Sulphate.

Viprynium Embonate.

Vitamin A.

Vitamin D.

Vitamin K.

Volatile Bitter Almond Oil, B.P. 1953.

Warfarin Sodium.

Fourth Schedule.

Regulation 12.

ADDITIVES.

Acetone, B.P.C.

Alcohol, B.P.

Amethocaine Hydrochloride, B.P.

Bacitracin, B.P.

Carmine Solution, A.P.F.

Cod Liver Oil, B.P.

Oil of Caraway, B.P.C.

Oil of Citronella, B.P.C.

Xylene, B.P.C. 1949.

­­­­_________

Fifth Schedule.

Regulation 14.

PHARMACEUTICAL BENEFITS THE PRESCRIBING OF WHICH IS SUBJECT TO CONDITIONS AND RESTRICTIONS.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Acetylsalicylic Acid Tablets B.P.	Any disease or condition in a pensioner
Soluble Acetylsalicylic Acid Tablets B.P.
Compound Acetylsalicylic Acid Tablets A.P.F.
Compound Acetylsalicylic Acid Tablets B.P.C.
Soluble Compound Acetylsalicylic Acid Tablets
Acrylic Resin ............................................	Ileostomy or colostomy conditions
Amphotericin B .........................................	Systemic fungal infections
Ampicillin .................................................	Any disease or condition in a pateient receiving treatment in or at an approved hospital
Androstanolone .........................................	Mammary carcinoma
With the written authority of the Director-General, long-term steroid therapy
Aneurine Hydrochloride Tablets B.P. .........	Any disease or condition in a pensioner
Ascorbic Acid Tablets B.P. ........................	Any disease or condition in a pensioner
Bemegride Injection B.P. ...........................	As an antidote to barbiturate and other hypnotic poisons
Benzol (Commercial) ................................	Ileostomy or colostomy conditions
Betamethasone	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection except Addison’s disease or other forms of adrenocortical hypoplasia
Busulphan Tablets B.P. ..............................	The leukaemias
Calciferol Tablets B.P. ...............................	Any disease or condition in a pensioner
With the written authority of the Director-General—
Hypoparathyroidism
Chronic hypoparathyroid tetany
Vitamin D-resistant rickets
Calciferol Solution B.P. .............................	Any disease or condition in a child under the age of twelve years or in a pensioner
Calcium Para-Aminosalicylate B.P.C. .........	Tuberculosis
Calcium Gluconate Effervescent Tablets	Hypoparathyrodism
Caramiphen Hydrochloride ........................	Parkinsonism
Chlorambucil ............................................	Malignant lymphoma and related conditions
Chloramine B.P.C, Tablets or Powder	Ileostomy or colostomy conditions
Chloramphenicol Capsules B.P. .................	Bacillary dysentery that is resistant both to the Sulphonamides and Streptomycin Sulphate
Bacterium coli meningitis, if other forms of treatment are unsuccessful
Granuloma inguinale
Friedlander bacillus infections
Haemophilus influenza infections
Lymphogranuloma venereum
Salmonella infections
Staphylococcal infections
Typhoid fever
Typhus and other rickettsial diseases
Urinary tract infections due to gram negative bacilli that are resistant to the Sulphonamides

Fifth Schedule—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Chloramphenicol B.P., Injection ...........	A disease or condition specified in this column in relation to Chloramphenicol Capsules
Chloramphenicol B.P., Oral Suspension	A disease or condition, specified in this column in relation to Chloramphenicol Capsules, in a child under the age of twelve years
Chlorotrianisene B.P.C. ........................	Carcinoma of the prostate
Chlorpheniramine Maleate Oral Linctus	Any disease or condition in a child under the age of twelve years
Chlorpromazine Hydrochloride B.P. .....	Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General, late-stage malignancy
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine or Thioridazine Hydrochloride
Chlortetracycline Capsules B.P. ............	As an alternative to the Penicillins in a person sensitive to the Penicillins
Actinomycosis
Amoebiasis
Bacterial endocarditis (Streptococcus faecalis), acute and sub-acute
Bacillary dysentery that is resistant both to the Sulphonamides and Streptomycin Sulphate
Bronchiectasis
Brucellosis
Chancroid
Fibrocystic disease of the pancreas
Granuloma inguinale
Friedlander bacillus infections
Leptospirosis
Lymphogranuloma venereum
Muscoviscidosis
Pneumonia that is resistant both to the Penicillins and the Sulphonamides
Pre-operative prophylaxis
Primary atypical pneumonia
Psittacosis
Puerperal infections
Rat-bite fever (Spirillum minus)
Staphylococcal infections
Trachoma that is resistant to the Sulphonamides
Typhus and other rickettsial diseases
Urinary tract infections due to gram negative bacilli that are resistant to the Sulphonamides
Whooping cough (Haemophilus pertussis)
Chlortetracycline Calcium ..............	A disease or condition, specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years
Chlortetracycline B.P. Granules

Fifth Schedule—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Clemizole Tannate Syrup ...........................	Any disease or condition in a child under the age of twelve years
Cloxacillin ................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Compound Codeine Phosphate Oral Tablet B.P.	Any disease or condition in a pensioner
Compound Codeine Phosphate Soluble Oral Tablet B.P.
Codeine Phosphate B.P. with Acetylsalicylic Acid B.P. Soluble Oral Tablet
Codeine Phosphate B.P. with Acetylsalicylic Acid B.P. Oral Tablet
Codeine Phosphate B.P. with Pentobarbitone Sodium B.P. and Phenacetin B.P. Oral Tablet
Codeine Phosphate B.P. with Acetylsalicylic Acid B.P. and Phenacetin B.P. Oral Tablet
Codeine Phosphate B.P. with Acetylsalicylic Acid B.P., Phenacetin B.P. and Caffeine B.P. Oral Tablet
Cod Liver Oil, B.P. ..................................	Any disease or condition in a child under the age of twelve years or in a pensioner
Cod Liver Oil Emulsion B.P. 1953
Colistin .....................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General—
Corticotrphin Injection B.P. .......................	A disease or condition specified in this column in relation to Cortisone Injection
Corticotrophin Gelatin Injection B.P.
Corticotrophin Zinc Hydroxide Injection B.P.	Hypsarrhythmia
	Salaam convulsions
The treatment of side effects of corticosteroid therapy
Cortisone Injection B.P. .............................	With the written authority of the Director-General—
Anaemia, acquired haemolytic
Addison’s disease or other forms of adrenocortical hypoplasia
Adrenalectomy, total
Adrenogenital syndrome
Behcet’s syndrome
Cranial arteritis
Cushing’s syndrome, including hyperadrenocorticalism
Dermatitis, acute exfoliative, associated with drug therapy
Dermatomyositis
Encephalomyelitis
Guillain-Barre syndrome
Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis
Hansen’s disease
Hepatitis, progressive or continuing, proven by biopsy or biochemistry
Hodgkin’s disease
Idiopathic hypercalcaemia
Keratoplasty

Fifth Schedule—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Cortisone Injection B.P.—continued.	The leukaemias
Lymphosarcoma and follicular lymphoma
Metastatic breast carcinoma
Nephritis, type II.
Nephrosis or nephrotic syndrome
Neuro-myelitis optica
Optic neuritis following removal of tumor of the brain
Panhypopituitarism
Pemphigus
Periarteritis nodosa
Progressive transverse myelitis
Pseudohermaphroditism
Purpura, Henoch’s
Purpura, thrombocytopenic
Reticulum cell sarcoma
Rheumatic carditis, acute
Sarcoidosis
Scleroderma
Severe reactions of the skin and mucosa following X-ray therapy
Splenic neutropenia and agranulocytosis
Status asthmaticus
Steroid therapy prior to operation in patients under steroid therapy
Stevens-Johnson syndrome
Still’s disease in a child under the age of sixteen years
Sympathetic ophthalmitis
Systemic lupus erythematosus
Temporal arteritis
Tropical and non-tropical sprue and all forms of mal-absorption associated with those diseases
Ulcerative colitis proven by sigmoidoscopy or radiological report
Uveitis, posterior
Cortisone Tablets B.P. ...............................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Cyanocobalamin Injection B.P. (other than 1,000 microgramme strength)

Established megalocytic anaemias
Cyanocobalamin Injection B.P., 1,000 microgramme strength	Neuroblastoma
Cymogran .................................................	With the written authority of the Director-General, phenylketonuria
Cycloserine ...............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Demethylchlortetracycline Hydrochloride	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Deoxycortone Acetate B.P. .......................	Addisons’s disease Total adrenalectomy
Deoxycortone Acetate Injection B.P.
Deoxycortone Acetate Implant B.P.
Desferrioxamine ........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Dexamethasone .........................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection except Addison’s disease or other forms of adrenocortical hypoplasia

Fifth Schedule—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Dextrochlorpheniramine Maleate Syrup	Any disease or condition in a child under the age of twelve years
Dicyclomine Hydrochloride, Oral Syrup	Any disease or condition in a child under the age of twelve years
Dienoestrol B.P., Cream ............................	Any disease or condition in a pensioner
Dienoestrol Tablets B.P. ............................	Carcinoma of the prostate
Mammary carcinoma
Any disease or condition in a pensioner
Diethyl Dithiolisophthalate ........................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Diiodohydroxyquinoline B.P., Vaginal Tablet	Trichomonal and monilial vaginitis
Diiodohydroxyquinoline B.P., Compound Effervescent Gynaecological Pessary	Trichomonal and monilial vaginitis
Dihydrostreptomycin Sulphate Injection B.P.	As an alternative to Streptomycin Sulphate in a person who is being treated for a disease or condition specified in this column in relation to Streptomycin Sulphate and who is allergic to Streptomycin Sulphate
Diloxanide Furoate ....................................	Amoebic dysentery
Diphenhydramine Hydrochloride B.P., Elixir	Any disease or condition in a child under the age of twelve years
Disodium Diethylstilboestrol Diphosphate	Carcinoma of the prostate
Ephedrine Hydrochloride with Phenobarbitone, Elixir	Any disease or condition in a child under the age of twelve years
Erythromycin B.P. ................................	A disease or condition in this column in relation to Chlortetracycline Capsules
Erythromycin Tablets B.P. ....................
Erythromycin Glucoheptonate
Erythromycin Propionate ......................
Erythromycin B.P., Oral Sachet	A disease or condition specified in this column in relation to Chlortetracycline Capsules in a child under the age of twelve years
Erythromycin B.P., Oral Suspension
Erythromycin Stearate, Oral Suspension
Ethinyloestradiol Tablets B.P. ....................	Turner’s syndrome
Pre-menopausal castration syndrome
Any disease or condition in a pensioner
Ethionamide ..............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Ethisterone Tablets B.P. .............................	Turner’s syndrome
Habitual abortion
Any disease or condition in a pensioner
Ethosuximide, Oral Syrup ..........................	Any disease or condition in a child under the age of twelve years
Ferric Hydroxide Colloidal Solution	Any disease or condition in a child under the age of twelve years
Ferrous Aminoacetosulphate Syrup
Ferrous Gluconate Elixir .......................
Ferrous Succinate Syrup .......................
Ferrous Sulphate Oral Drops
Fludrocortisone Acetate..............................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Fluoxymesterone .......................................	Mammary carcinoma
Folic Acid B.P. ....................................	Macrocytic anaemic
Folic Acid Tablets B.P..........................	Sprue or the sprue-like syndrome
Formyl-Tetrahydropteroyl Glutamic Acid	Any disease or condition in a patient receiving treatment in or at an approved hospital
Fusidic Acid ........................................

Fifth Schedule—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Griseofulvin ..........................................	With the written authority of the Director-General—
For the treatment of any of the following diseases, the diagnosis of which has been confirmed by pathological report:—
Epidermophyton floccosum
Microsporum audouni
Microsporum canis
Microsporum gypseum
Trychophyton interdigitale
Trichophyton mentagrophytes
Trichophyton rubrum
Trichophyton schoenleini
Trichophyton sulphureum
Trichophyton verrucosum
Haemophilus Influenza Bacterial Serum	Any disease or condition in a patient receiving treatment in or at an approved hospital
Hexachlorophene, 3% with Entsufon
Hexachlorophene, 3% with Lissapol
Hexachlorophene, 1.5% with Soap Solution
Hydrocalciferol .....................................	Parathyroid deficiency
Hydrocortisone Injection B.P. .................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Hydrocortisone Sodium Succinate B.P.	With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report
Hydrocortisone Sodium Succinate Injection B.P.	Acute adrenal failure due to a medical or surgical crisis
Stevens-Johnson syndrome
Hydroxocobalamin Injection, 100 microgramme strength	Established megalocytic anaemia
Hydroxocobalamin Injection, 1,000 microgramme strength	Sub-acute combined degeneration of the cord
Neuroblastoma
Isionazid Tablets B.P. ............................	Hansen’s disease
Tuberculosis
Kanamycin Sulphate ..............................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Levorphanol Tartrate B.P.C. ...................	Obstetrical use
Severe intractable pain
Liothyronine .........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Lissapol Deodorant Detergent (Lissapol N100 with Spearmint Oil and Cetrimide)	Ileostomy or colostomy condition
Lofenalac ..............................................	With the written authority of the Director-General, phenylketonuria
Malt Extract B.P. ...................................	Any disease or condition in a child under the age of twelve years or in a pensioner
Malt Extract with Cod Liver Oil B.P.
Mebhydrolin Suspension ........................	Any disease or condition in a child under the age of twelve years
Medroxyprogesterone Acetate ................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Mepyramine Maleate Elixir ....................	Any disease or condition in a child under the age of twelve years
Mercaptopurine Tablets B.P. ..................	Allergic angiitis
Periarteritis
Systemic lupus erythematosus
The leukaemias

Fifth Schedule—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Methdilazine Hydrochloride Syrup .........	Any disease or condition in a child under the age of twelve years
Methenolone Acetate ............................	Senile osteoporosis proven by radiological report
With the written authority of the Director-General, long-term steroid therapy
Methenolone Oenanthate .......................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Methicillin ............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Methotrexate ........................................	The leukaemias and neo-plastic disease
Methyl Androstanolone .........................	Mammary carcinoma
With the written authority of the Director-General, long-term steroid therapy
Methylandrostenediol ............................	Senile osteoporosis proven by radiography
With the written authority of the Director-General, long-term steroid therapy
Milk Powder, Synthetic .........................	With the written authority of the Director-General, galactosaemia
Minafen ...............................................	With the written authority of the Director-General, phenylketonuria
Mitomycin ............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Morphine with Tacrine, 30 mg.-15 mg. Oral Tablet	Severe intractable pain
Mustine Injection B.P. .........................	Malignant lymphoma and related conditions Mammary carcinoma
Nandrolone Phenylpropionate	With the written authority of the Director-General, long-term steroid therapy
Nandrolone Decanoate ........................
Neomycin Sulphate B.P., in a form other than Eye Drops	Any disease or condition in a patient receiving treatment in or at an approved hospital
Nicotinamide Tablets B.P. .....................	Any disease or condition in a pensioner
Nicotinic Acid Tablets B.P. ...................	Any disease or condition in a pensioner
Nitrofurantoin .......................................	Urinary tract infections
Nitrofurantoin Suspension .....................	Any urinary tract infection in a child under the age of twelve years
Nitromin ...............................................	Malignant lymphoma and related conditions
Norethandrolone ...................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Novobiocin Calcium B.P. ....................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Novobiocin Sodium B.P. .....................
Novobiocin Tablets B.P. ......................
Nystatin ................................................	Proven monilia infections
Orciprenaline ........................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Oxymesterone ......................................	Senile osteoporosis proven by radiological report
With the written authority of the Director-General, long-term steriod therapy
Oxytetracycline Tablets B.P.	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Oxytetracycline Injection B.P.
Oxytetracycline and Procaine Injection B.P.
Calcium Di-Oxytetracycline ..................	A disease or condition, specified in this column in relation to Chlortetracycline Capsules, in a child under the age of twelve years
Oxytetracycline Paediatric Drops
Oxytocin Nasal Spray...............................	Induction of labour
Pancreatin B.P. ...................................	Fibrous disease of the pancreas
Pancreatin Enzyme 4, U.S.N.F. XI.	Pancreatico-duodenectomy
Pancrex 5 ...........................................	Pancreatic steatorrhea
Para-Aminosalicylic Acid ......................	Tuberculosis
Paracetamol, Oral Suspension ................	Any disease or condition in a child under the age of twelve years

Fifth Schedule—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Paramethasone Acetate ..............................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Paraffin Liquid Emulsion B.P. ....................	Any disease or condition in a pensioner
Pethidine and Levallorphan Tartrate ...........	Obstetrical use
Phenoxymethylpenicillin B.P., Oral Suspension	Any disease or condition in a child under the age of twelve years
Phenoxymethylpenicillin (Benzathine Salt), Oral Suspension
Phenoxymethylpenicillin Calcium B.P., Oral Suspension
Phenoxymethylpenicillin (Hydrabamine Salt), Oral Suspension
Phenoxymethylpenicillin Potassium B.P., Oral Suspension
Benzylpenicillin B.P., with Procaine Penicillin B.P. and Streptomycin Sulphate B.P.	Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Phenacetin ................................................	Any disease or condition in a pensioner
Phenytoin Sodium B.P., Oral Suspension	Any disease or condition in a child under the age of twelve years
Phytomenadione Injection B.P. ...................	Antidote to anticoagulants
Piperazine Citrate B.P., Elixir .....................	Any disease or condition in a child under the age of twelve years
Pituitary Posterior Lobe B.P.C., Insufflation	Diabetes insipidus
Polydimethylsiloxanes ...............................	Ileostomy or colostomy conditions
Prednisolone Disodium Phosphate ..............	With the written authority of the Director-General, ulcerative colitis proven by sigmoidoscopy or radiological report
Prednisolone Tablets B.P. ..........................	With the written authority of the Director-General—
Anaemia, acquired haemolytic
Adrenogenital syndrome
Behcet’s syndrome
Cranial arteritis
Cushing’s syndrome, including hyperadrenocorticalism
Dermatitis, acute exfoliative, associated with drug therapy
Dermatomyositis
Encephalomyelitis
Guillain—Barre syndrome
Hamman-Rich syndrome—diffuse interstitial pulmonary fibrosis
Hansen’s disease
Hepatitis, progressive or continuing, proven by biopsy or biochemistry
Hodgkin’s diesease
Idiopathic hypercalcaemia
Inflammatory conditions of the uveal tract and retina
Keratoplasty
The leukaemias
Lymphosarcoma and follicullar lymphoma
Metastatic breast carcinoma
Nephritis, type II.
Nephrosis or nephrotic syndrome
Neuro-myelitis optica
Nodular non-suppurative pannicultitis (Christian-Weber disease)

Fifth Schedule—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Prednisolone Tablets B.P.—continued.	Optic neuritis following removal of tumour of the brain
Panhypopituitarism
Pemphigus
Periarteritis nodosa
Progressive transverse myelitis
Pseudohermaphroditism
Purpura, Henoch’s
Purpura, thrombocytopenic
Reticulum cell sarcoma
Rheumatic carditis, acute
Sarcoidosis
Scleroderma
Severe reactions of the skin and mucosa following X-ray therapy
Splenic neutropena and agranulocytosis
Status asthmaticus
Steroid therapy prior to operation in patients under steroid therapy
Stevens-Johnson syndrome
Still’s disease in a child under the age of sixteen years
Sympathetic ophthalmitis
Systemic lupus erythematosus
Temporal arteritis
Tropical and non-tropical sprue and all forms of mal-absorption associated with those diseases
Ulcerative colitis proven by sigmoidoscopy or radiological report
Uveitis, posterior
Methyl Prednisolone ..................................	With the written autority of the Director General, a disease or condition specified in this column in relation to Prednisolone Tablets
Prednisolone Acetate B.P. ..........................	With the written authority of the Director-General a disease or condition specified in this column in relation to Cortisone Injection except Addison’s disease or other forms of adrenocortical hypoplasia
Prednisolone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Prednisolone Sodium Hemisuccinate	Any disease or condition in a patient receiving treatment in or at an approved hospital
Prednisone Tablets B.P. .............................	With the written authority of the Director-General—
A disease or condition specified in this column in relation to Cortisone Injection except Addison’s disease or other forms of adrenocortical hypoplasia and total adrenalectomy
Nodular non-suppurative panniculitis (Christian-Weber disease)
Inflammatory conditions of the uveal tract and retina
Prednisone B.P. with Magnesium Trisilicate B.P. and Dried Aluminium Hydroxide Gel. B.P.	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection

Fifth Schedule—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Progesterone Injection B.P. ..................	Habitual abortion
Promethazine Hydrochloride B.P., Elixir	Any disease or condition in a child under the age of twelve years
Prophenpyridamine Maleate, Oral Syrup	Any disease or condition in a child under the age of twelve years
Protoveratrines A ................................	Hypertensive crisis
Pyrazinamide ......................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Pyridine Aldoxime Methiodide .............	Any disease or condition in a patient receiving treatment in or at an approved hospital
Pyridoxine Hydrochloride, Oral Tablet, B.P.C.	Peripheral neuritis due to isoniazid therapy
	Radiation sickness
Pyridostigmine Injection B.P. ...............	Myasthenia gravis
Pyridostigmine Tablets B.P. .................	Myasthenia gravis
Quinethazone ..................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Rheomacrodex, 10% in Dextrose
Riboflavine Tablets B.P. ......................	Any disease or condition in a pensioner
Ristocetin ............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Senna Fruit Extract ..............................	Any disease or condition in a pensioner
Sobee ..................................................	With the written authority of the Director-General, galactosaemia
Sodium Aminosalicylate B.P.	Tuberculosis
Sodium Aminosalicylate Tablets B.P.
Sodium Folate .....................................	Macrocytic anaemia
Sprue or the sprue-like syndrome
Spiramycin .........................................	Staphylococcal infections that are resistant both to the Tetracyclines and to the Penicillins
Spironolactone ....................................	Any disease or condition in a patient receiving treatment in or at an approved hospital

Stilboestrol B.P. .................................	Carcinoma of the prostate
Stilboestrol Tablets B.P. .....................	Mammary carcinoma
Any disease or condition in a pensioner
Streptomycin Sulphate B.P. ..................	Bacillary dysentery that is resistant to the Sulphonamides
Brucellosis
Chancroid
Endocarditis due to Streptococcus faecalis or Streptococcus viridans
Friedlander bacillus infections
Haemophilus influenzae infections Plague
Pseudomonas pyocyaneus infections
Rat-bite fever (Streptobacillus moniliformis)
Salmonella infections
Surgical conditions of the bowel (pre-operative and post-operative)
Surgical conditions of the thoracic organs
Tuberculosis
Tularaemia
Urinary tract infections that are resistant to the Sulphonamides
Streptomycin Sulphate Injection B.P. ....	A disease or condition specified in this column in relation to Streptomycin Sulphate
Streptomycin Sulphate B.P. with Benzylpenicillin Sodium, B.P.	Endocarditis due to Streptococcus faccalis or Streptococcus viridans
Sulphadimethoxine Suspension	Any disease or condition in a child under the age of twelve years
Sulphadimidine Oral Suspension
Sulphaphenazole Syrup ....................
Sulphasalazine ....................................	Ulcerative colitis

Fifth Schedule—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may he prescribed) for supply under Part VII. of the Act.
Sulthiame ...................................................	For use where other anti-convulsants have failed
Surgical cement ..........................................	Ileostomy or colostomy conditions
Sustanon ..................................................	Castration syndrome Mammary carcinoma
Testosterone Implants B.P. ........................
Testosterone Oenanthate ...........................
Testosterone Propionate Injection B.P.	Castration syndrome
Testosterone Propionate B.P.	Kline felter Reifenstein Albright syndrome
Methyltestosterone Tablets B.P.	Mammary carcinoma
Tetracycline with a buffering agent and Amphotericin B	A disease or condition specified in this column in relation to Tetracycline with Nystatin in a child under the age of twelve years
Tetracycline Capsules B.P. ........................	A disease or condition specified in this column in relation to Chlortetracycline Capsules
Tetracycline Tablets B.P............................
Tetracycline and Procaine Injections B.P.
Tetracycline Hydrochloride B.P., with a buffering agent—Capsules
Tetracycline Injection B.P. ........................
Tetracycline with Oleandomycin Capsules
Pyrrolidino-Methyl-Tetracycline
Tetracycline with a buffering agent—Oral Suspension	A disease or condition, specified in this column in relation to Chloretracycline Capsules, in a child under the age of twelve years
Tetracycline with a buffering agent—Paediatric Drops
Tetracycline with Oleandomycin—Oral Suspension
Tetracycline with Oleandomycin—Paediatric Drops
Tetracycline with Nystatin............................	Broad spectrum antibiotic therapy of premature infants, of patients under steroid therapy or of cases complicated by intestinal moniliasis
A second or repeated course of broad spectrum antibiotic therapy for a disease or condition specified in this column in relation to Chlortetracycline Capsules
Thenalidine Tartrate Syrup ..........................	Any disease or condition in a child under the age of twelve years
Thioridazine Hydrochloride .........................	Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine or Thioridazine Hydrochloride
Thyrotropin ................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Tragacanth B.P., Powder .............................	Ileostomy or colostomy conditions

Fifth Schedule—continued.

Pharmaceutical Benefit.	Purpose for which, and the Conditions subject to which, the Pharmaceutical Benefit may be prescribed (including any restrictions as to the persons for whose treatment it may be prescribed) for supply under Part VII. of the Act.
Triamcinolone .............................................	With the written authority of the Director-General, a disease or condition specified in this column in relation to Cortisone Injection
Triamterene ...............................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Triaziquone ...............................................
Triethylene Thiosphosphoramide ..................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Tretamine ....................................................	Malignant lymphoma and related conditions
Trifluoperazine ............................................	Any disease or condition in a pensioner
Any disease or condition in a patient receiving treatment in or at an approved hospital
With the written authority of the Director-General, the treatment of a mental disorder in a person who has been discharged from an approved hospital at which he received treatment for a mental disorder and who is living in a place remote from an approved hospital
The treatment of a mental disorder in a person who has, after treatment for a mental disorder, been discharged from an approved hospital if a medical officer of the hospital gives a certificate certifying that that person received treatment at the hospital and may require further treatment with Chlorpromazine Hydrochloride, Trifluoperazine or Thioridazine Hydrochloride
Trimeprazine Tartrate ..................................	Any disease or condition in a child under the age of twelve years
Trimetaphan Camphorsulphonate .................	Hypotensive for anaesthesia
Triprolidine Hydrochloride, Elixir ................	Any disease or condition in a child under the age of twelve years
Vadrine .....................................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Vancomycin Hydrochloride .......................
Velactin ......................................................	With the written authority of the Director-General, galactosaemia
Veriloid .......................................................	Hypertensive crisis
Viomycin Sulphate ......................................	Any disease or condition in a patient receiving treatment in or at an approved hospital
Viomycin Sulphate and Viomycin Pantothenate Combination	Any disease or condition in a patient receiving treatment in or at an approved hospital
Vitamin A Activity with Aneurine Hydrochloride B.P., Riboflavine B.P., Nicotinamide B.P., Ascorbic Acid B.P. and Vitamin D	Any disease or condition in a pensioner
Vitamin A Oral Tablets ................................	Any disease or condition in a pensioner
Concentrated Vitamin A Solution B.P.	Any disease or condition in a child under the age of twelve years or in a pensioner
Concentrated Vitamin A and D Solution B.P.
Concentrated Vitamin D Solution B.P.	Tetany
Any disease or condition in a child under the age of twelve years or in a pensioner

By Authority: A. J. Arthur, Commonwealth Government Printer, Canberra.